Sue Smith
Corporate Officer/Principal chez Y-MABS THERAPEUTICS, INC.
Provenance du réseau au premier degré de Sue Smith
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Sue Smith via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BB BIOTECH AG | Financial Conglomerates | Director/Board Member | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Scopia Capital Management LP
 Scopia Capital Management LP Investment ManagersFinance Scopia Capital Management LP (Scopia) is an independent, SEC-registered investment advisor and alternative asset management firm headquartered in New York City. The firm was founded in 2001 and is majority owned by Matthew Sirovich and Jeremy Mindich. Scopia provides investment advisory services on a discretionary basis to clients that are pooled investment vehicles which are intended for institutional investors and other sophisticated investors. | Investment Managers | Portfolio Manager-Equities | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member | |
Citigroup Global Markets, Inc.
 Citigroup Global Markets, Inc. Investment Banks/BrokersFinance Citigroup Global Markets, Inc. engages in the provision of brokerage, investment banking, and asset management services to individuals, businesses, and governments. The company was founded by Julie E. Silcock and is headquartered in New York, NY. | Investment Banks/Brokers | Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity | |
| GENMAB A/S | Pharmaceuticals: Major | Chief Operating Officer Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IPC CORPORATION LTD | Hotels/Resorts/Cruise lines | President | |
I. P. Cons ApS
 I. P. Cons ApS Real Estate DevelopmentFinance I. P. Cons ApS engages in the trading and leasing activity with property and equipment. It also offers investment and financing activities. The company was founded by Claus Juan Møller-San Pedro on December 23, 1994 and is headquartered in Rungsted Kyst, Denmark. | Real Estate Development | Chief Executive Officer | |
CIS Bio International SA
 CIS Bio International SA Pharmaceuticals: MajorHealth Technology CIS Bio International SA engages in the distribution of radiopharmaceuticals for diagnosis and therapy. The company is headquartered in Saclay, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Arizona | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree | |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Operating Officer | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
| NATERA, INC. | Medical Specialties | Director/Board Member | |
| Women Business Leaders of the US Health Care Industry Fnd | Corporate Officer/Principal | ||
| Genmab MN, Inc. | President | ||
Terranol A/S
 Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
| Synthélabo Scandinavia A/S | Chief Tech/Sci/R&D Officer | ||
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Founder | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
| Stephen M. Ross School of Business | College/University | Masters Business Admin | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| University of Michigan Medical School | College/University | Doctorate Degree | |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member | |
| Lund-Hansen Consulting ApS | Corporate Officer/Principal | ||
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman | |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sofinnova Investments, Inc. (Investment Management)
 Sofinnova Investments, Inc. (Investment Management) Investment ManagersFinance Sofinnova Investments, Inc. (Investment Management) (Sofinnova-IM) is the investment management division of Sofinnova Investments, Inc., a venture capital firm headquartered in Menlo Park, California. Founded in 1974, Sofinnova-IM serves as an investment adviser to pooled investment vehicles and separately managed accounts. | Investment Managers | Chief Executive Officer | |
| SCILEX HOLDING COMPANY | Pharmaceuticals: Other | Director/Board Member | |
| Hamill Advisory Group LLC | Founder | ||
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 34 |
| Danemark | 12 |
| France | 3 |
| Irlande | 3 |
| Suisse | 2 |
Sectorielle
| Health Technology | 27 |
| Finance | 8 |
| Consumer Services | 8 |
| Commercial Services | 6 |
Opérationnelle
| Director/Board Member | 86 |
| Independent Dir/Board Member | 34 |
| Corporate Officer/Principal | 27 |
| Director of Finance/CFO | 14 |
| Chairman | 8 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Healy | 50 |
| David Gill | 32 |
| Laura Hamill | 15 |
| Gérard Ber | 12 |
| Claus Juan Møller-San Pedro | 10 |
| Torben Lund-Hansen | 8 |
| Ashutosh Tyagi | 7 |
| Michael Rossi | 7 |
| Johan Ernst Wedell-Wedellsborg | 6 |
| Bo Kruse | 5 |
| Joris Wilms | 4 |
| Thomas Gad | 3 |
| Steen Lisby | 3 |
| Vignesh Rajah | 1 |